Stay updated on Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Sign up to get notified when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.

Latest updates to the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedCore status messaging updated and version bumped from v3.1.0 to v3.2.0; emphasizes funding-related operational status for NIH Clinical Center.SummaryDifference2%

- Check26 days agoChange DetectedVersion metadata updated from v3.0.2 to v3.1.0. No substantive content changes detected.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.1%

- Check55 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as specific drug information related to Dolutegravir and associated MedlinePlus topics. Notably, previous drug information for Lamivudine has been removed.SummaryDifference3%

- Check69 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%

Stay in the know with updates to Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.